Canada Life
ODT

Canada Life’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Canada Life’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-678
Closed -$2K – 2596
2021
Q1 		$2K Hold
678
– – ﹤0.01% 2589
2020
Q4 		$13K Hold
678
– – ﹤0.01% 2586
2020
Q3 		$9K Hold
678
– – ﹤0.01% 2532
2020
Q2 		$29K Hold
678
– – ﹤0.01% 2414
2020
Q1 		$19K Hold
678
– – ﹤0.01% 2388
2019
Q4 		$22K Buy
+678
New +$21K ﹤0.01% 2481
2019
Q3 		– Sell
-1,277
Closed -$46K – 2551
2019
Q2 		$46K Buy
+1,277
New +$30.6K ﹤0.01% 2463

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Canada Life's ODT Position: Q2 2021 in Review

Canada Life sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 678 shares — an estimated $2K sold.

Canada Life first reported a position in ODT in Q2 2019 and held it in 7 quarters. The position peaked at $46K in Q2 2019. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

  • Canada Life reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Canada Life sold 678 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $2K.
  • Canada Life first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Canada Life's Odonate Therapeutics, Inc. Common Stock position peaked at $46K in Q2 2019.
  • 69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Canada Life's 13F filing for Q2 2021, filed 11 Aug 2021.